Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0002034863-24-000003
Filing Date
2024-10-24
Accepted
2024-10-24 11:28:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 12072
  Complete submission text file 0002034863-24-000003.txt   13594
Mailing Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850
Business Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 301-869-9683
OPGEN INC (Subject) CIK: 0001293818 (see all company filings)

EIN.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-88842 | Film No.: 241391301
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)

Mailing Address NO.1 JALAN ANGGERIK DISA 31/185A BROADLEAF RESIDENCE, KOTA KEMUNING SHAH ALAM N8 40460
Business Address
Tan Honjian (Filed by) CIK: 0002033707 (see all company filings)

Type: SCHEDULE 13D